Clinical Trials Sponsored by Shanghai Hongdian Medical CO., LTD

Total 1996 results

Shanghai Hongdian Medical CO., LTD

Recruiting

FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension

Hypertension

China
Shenyang Tonglian Group CO., Ltd

Terminated

Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients

Coronavirus Disease 2019

United States, Brazil, Mexico, Argentina, Philippines, Ukraine
Shanghai NewMed Medical Co., Ltd.
Shanghai Phigine Medical Technology Co., Ltd.

Not yet recruiting

Phitys I™ Percutaneous Left Ventricular Assist System Study

Coronary Artery Disease

China
Shanghai NewMed Medical Co., Ltd.

Recruiting

Valveclip® Transcatheter Mitral Valve Repair Study

Mitral Regurgitation

China
Shanghai NewMed Medical Co., Ltd.

Active, not recruiting

PrizValve® Transcatheter Aortic Valve Replacement Study

Aortic Valve Stenosis

China
Shanghai NewMed Medical Co., Ltd.

Completed

Mi-thos® Transcatheter Mitral Valve Replacement(First-in-Man Study)

Mitral Valve Regurgitation

China
Shanghai NewMed Medical Co., Ltd.

Recruiting

Mi-thos® Transcatheter Mitral Valve Replacement Study

Mitral Valve Regurgitation

China
Shanghai NewMed Medical Co., Ltd.
Shanghai Zhongshan Hospital

Recruiting

Prizvalve® Transcatheter Valve-in-Valve Implantation Exploratory Study

Failing Bioprosthetic Valve

China
Shanghai BDgene Co., Ltd.
Shanghai Children's Medical Center

Not yet recruiting

Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia

β-thalassemia
Shanghai NewMed Medical Co., Ltd.
Shanghai Zhongshan Hospital

Recruiting

Prizvalve® Transcatheter Atrioventricular Valve Replacement Study

Atrioventricular Annular Calcification | Failed Prosthetic Atrioventricular Valve/ Annulus Repair

China
Shanghai Bomaian Medical Technology Co., Ltd

Not yet recruiting

Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula

Peripheral Arterial Disease
Shanghai Huihe Medical Technology Co., Ltd

Not yet recruiting

A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Safety of the Transcatheter Tricuspid Valvuloplasty System in Patients With Severe or Above Tricuspid Regurgitation

Tricuspid Regurgitation
Shanghai Bomaian Medical Technology Co., Ltd

Not yet recruiting

To Verify the Efficacy and Safety of Rapamycin Coated Peripheral Balloon Catheter in the Treatment of Femoral Popliteal Artery Disease

Peripheral Arterial Disease

China
Shanghai Shenqi Medical Technology Co., Ltd

Recruiting

SQ-Kyrin TMVr FIM Study

Mitral Regurgitation

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's Firesorb BVS: FUTURE-III (FUTURE-III)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Coronary Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Drug Eluting Stent

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II (FUTURE-II)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke (SAFE-PROTECT)

Stroke | Atrial Fibrillation

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )

Coronary Heart Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear

Rotator Cuff Tears
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

Percutaneous Coronary Intervention | Drug-Eluting Stents | Tomography, Optical Coherence

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

The First-In-Man Pilot Study of Firehawk

Coronary Heart Disease
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial (FOCUS)

Coronary Heart Disease

China
Shanghai Shenqi Medical Technology Co., Ltd

Not yet recruiting

Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications

Portal Hypertension

China
Enlight Medical Technologies (Shanghai) Co., Ltd

Recruiting

Clinical Study of PTFE Covered Stent for Treating Portal Hypertension

Portal Hypertension

China
Shanghai Shenqi Medical Technology Co., Ltd

Not yet recruiting

Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide®

Coronary Artery Disease

China
Enlight Medical Technologies (Shanghai) Co., Ltd

Recruiting

A Clinical Study to Evaluate the Safety and Effectiveness of Novabel Bioabsorbable Steroid-releasing Stent for the Chronic Sinusitis

Chronic Sinusitis

China
Shanghai Carnation Medical Technology Co., Ltd

Recruiting

A Multicenter Controlled Study to Evaluate Efficacy and Safety of Focused Ultrasound Device (FUBA5200) for Noninvasive Fat Reduction

Body Sculpting

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) (LARGE-ONE)

Coronary Artery Disease

China
Shanghai Huihe Medical Technology Co., Ltd

Not yet recruiting

Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip TM Transcatheter Annuloplasty System (TriStar)

Tricuspid Regurgitation
Shanghai Youhe Medical Technology Co., Ltd.

Recruiting

ENB Vs. Conventional Bronchoscopy With Fluoroscopy for Safe and Effective Biopsy of Pulmonary Lesions

Lung Neoplasms | Pulmonary Neoplasm

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's DCB

Coronary Artery In-stent Restenosis
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF)

Coronary Artery Disease

China
Enlight Medical Technologies (Shanghai) Co., Ltd

Active, not recruiting

Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation

Degenerative Mitral Valve Disease

China
Shanghai Shenqi Medical Technology Co., Ltd

Active, not recruiting

Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation

Functional Mitral Regurgitation

China
Shanghai Shangyang Medical Technology Co., Ltd.

Active, not recruiting

PFA for Paroxysmal Atrial Fibrillation

Paroxysmal Atrial Fibrillation

China
Shanghai Huihe Medical Technology Co., Ltd

Enrolling by invitation

Polyvinyl Alcohol Embolization Microspheres

Primary Liver Cancer

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

Coronary Artery Disease

China
Shanghai WiseGain Medical Devices Co., Ltd.

Unknown

Randomized Controlled Trial of Renal Denervation for Resistant Hypertension

Hypertension

China
Shanghai Huihe Medical Technology Co., Ltd

Recruiting

Feasibility Study of Treating Tricuspid Regurgitation With K-ClipTM Transcatheter Annuloplasty System

Tricuspid Regurgitation

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Optical Coherence Tomography | Angiography | Intravascular Ultrasound

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment (T-P)

Coronary Artery Disease | Coronary Stenosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

A First-in-Man Study of the Firesorb BVS (FUTURE-I) (FUTURE-I)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)

Coronary Artery Disease

Denmark
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease (Firehawk_38)

Coronary Heart Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial (TARGET-IV_NA)

Coronary Artery Disease

United States, Denmark, Canada, Belgium, Netherlands
Shanghai Shenqi Medical Technology Co., Ltd

Completed

Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization

Peripheral Arterial Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Calcification

China

Clinical Trials Sponsored by Shanghai Hongdian Medical CO., LTD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations